Naveen Pemmaraju

Naveen Pemmaraju and Gaby Hobbs Discuss Advancing Disease Modification in MPNs

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, posted on X:

“Always lovely to chat with Dr Gaby Hobbs about one of our mutual passion areas: improving disease modification and considering new response criteria in MPNs!”

More posts featuring Naveen Pemmaraju.